Join the club for FREE to access the whole archive and other member benefits.

Eric Verdin

CEO & President at Buck Institute for Research on Aging

Eric Verdin is the president and chief executive officer of the Buck Institute for Research on Aging. A native of Belgium, Dr. Verdin received his Doctorate of Medicine (MD) from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Dr. Verdin is also a professor of medicine at University of California, San Francisco. Dr. Verdin joined the Buck in 2016 after spending the previous 20 years as a senior investigator at the Gladstone Institutes, where he served as associate director from 2004 to 2016.

Dr. Verdin’s laboratory focuses on the role of epigenetic regulators in the aging process. His laboratory was the first to clone a family of enzymes called HDACs, which regulate histone acetylation. Dr. Verdin studies how metabolism, diet, and small molecules regulate the activity of HDACs and sirtuins, and thereby the aging process itself and its associated diseases, including Alzheimer’s. He has published more than 210 scientific papers and holds more than 15 patents. He is a highly cited scientist and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation.

He's founder of Academy for Health & Lifespan Research and Scientific Advisory Board Member at Genflow Biosciences.

Visit website: https://www.buckinstitute.org/lab/verdin-lab/

 eric-verdin-490212

 EricVerdin

See also: Institute Buck Institute - Independent biomedical research institute focused on aging

Mentioned in this Resource

Academy for Health and Lifespan Research (AHLR)

World's aging researchers unite to accelerate breakthroughs in longevity

Eric Verdin is also referenced in the following:

Academy for Health and Lifespan Research (AHLR)

World's aging researchers unite to accelerate breakthroughs in longevity

ARDD 2021 - 8th Aging Research and Drug Discovery Meeting

31-Aug-2021 to 03-Sep-2021

Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.

ARDD 2022 - 9th Aging Research and Drug Discovery Meeting

29-Aug-2022 to 02-Sep-2022

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Biomarkers of Aging Consortium

Establishing Reliable Biomarkers of Aging for Longevity Interventions

Ending Age-Related Diseases (EARD) 2021

19-Aug-2021 to 22-Aug-2021

Hear the latest developments from the leading experts in rejuvenation biotechnology research

Forever Young?

Lara Lewington interviews scientists, commentators and a "professional rejuvenation athlete" (Bryan Johnson)

Genflow Biosciences

Developing medicines that potentially halt, slow or reverse the aging process

Global Healthspan Summit 2023

29-Nov-2023 to 30-Nov-2023

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Longevity Investors Conference 2022

28-Sep-2022 to 30-Sep-2022

Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger and Dr. Tobias Reichmuth

Longevity Investors Conference 2023

27-Sep-2023 to 29-Sep-2023

Conference gathering longevity experts and investors at one place hosted by Marc P. Bernegger, Dr. Tobias Reichmuth and Daniel Koetser

Longevity Leaders World Congress 2022

26-Feb-2022 to 27-Feb-2022

Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)

Longevity Med Summit

04-May-2023 to 05-May-2023

Annual gathering of the entire longevity ecosystem to tackle the aging problem

Longevity Summit Dublin 2023

17-Aug-2023 to 20-Aug-2023
Club discount available - click here

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

XPRIZE Launches a $101 Million Health Competition

Live stream of XPRIZE Healthspan launch on YouTube

Eric Verdin Blog Posts

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
16-Jul-2020

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy

Great to see a startup willing to explicitly state they are treating ageing itself as a disease

Eric Verdin News

Buck Institute and Phenome Health team up to advance scientific wellness

Buck Institute - 27-Sep-2023

Collaboration of data and discovery to extend healthspan for everyone

Read more...

Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit

Lifespan.io (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials

Read more...

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Read more...

Amazentis’ proprietary Urolithin A-clinically proven to improve muscle function

EurekAlert! - 17-May-2022

Mitopure will be offered inside Nestlé Health Science products

Read more...

Selah Therapeutics launched to focus on ketone-based therapies for heart disease

Longevity Technology - 13-May-2022

Treatment options for diseases of aging - from the makers of metabolic switch

Read more...

Summary of Eric Verdin presentation at End Age-Related Diseases 2021

Live Forever Club - 21-Aug-2021

Discusses causes and prevention of NAD depletion with a focus on CD38 consumption

Read more...

Ultra-pure NMN supplement - Interview with Eric Verdin by Longevity blog

Longevity blog - 28-May-2021

Explains about human use of NMN-C, future of NAD boosters, and his personal longevity strategy

Read more...

Chronic inflammation promotes NAD+ decline during aging

Buck Institute - 16-Nov-2020

Senescent cells induce NAD+ decline via activation of CD8 macrophages

Read more...

Measuring frailty with blood biomarkers could lead to early detection

Longevity Technology - 14-Sep-2020

Circulating CRP and albumin (among other molecules) found to be related to frailty

Read more...

Longevity Leaders' latest report on how longevity is disrupting the world

Longevity Leaders (LSX) - 01-Jan-2020

An interesting collection of interviews and white-papers with industry leaders

Read more...

Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin

Longevity Technology - 03-Oct-2019

Includes updates on NAPA Therapeutics and BHB Therapeutics

Read more...

Aging focused biotechs forms AI based joint venture

FierceBiotech - 14-Aug-2018

Groundbreaking research biotechs performs aging research together for longevity

Read more...